CMED Related Analyst Ratings
-
Brean Murray Downgrades China Medical (CMED) to Hold; Valuation Call
-
Brean Murray Assumes Coverage on China Medical Technologies (CMED) with a Buy
-
Brean Murray Upgrades China Medical Technologies (CMED) to Buy
-
Morgan Stanley Initiates Coverage on China Medical (CMED) with an Outperform
-
Bear Stearns Initiates Coverage on China Medical Technologies (CMED) with an Outperform
-
Brean Murray downgrades China Medical Technologies (CMED) to Hold
-
Brean Murray upgrades China Medical Technologies (CMED) to Buy
-
Goldman Sachs raises its price target on China Medical Technologies I(CMED) to $36
-
Brean Murray Starts China Medical Tech (CMED) at Hold
-
Goldman Sachs downgrades China Medical Tech (CMED) to Neutral
-
UBS upgrades China Medical Technologies Inc. (CMED) to Buy
-
Goldman Sachs Starts China Medical (CMED) at In-Line
-
UBS upgrades China Medical (CMED) to Neutral
Back to CMED Stock Lookup
